BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Nordic AML Group - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Nordic AML Group
X-ORIGINAL-URL:https://www.namlg.org
X-WR-CALDESC:Events for Nordic AML Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230824
DTEND;VALUE=DATE:20230826
DTSTAMP:20260501T021018
CREATED:20231123T094750Z
LAST-MODIFIED:20231123T095448Z
UID:10000001-1692835200-1693007999@www.namlg.org
SUMMARY:Nordic AML Meeting 2023
DESCRIPTION:Registration \nDay 1: Thursday August 24\, 2023\n09:45-10:00:    Welcome and Opening: Bjørn Tore Gjertsen (Chair\, Nordic AML Group) \nSession 1: Chairs: Bjørn Tore Gjertsen\, Jeffrey Tyner\n10:00-10:30:    NAMLG Keynote Lecture \n                           Sören Lehmann: Chromatin organization – the next step in the characterization of AML \n10:30-10:50:    Jorrit Enserink: Drug sensitivity Screen in AML undergoing intensive chemotherapy \n10:50-11:10:    Krister Wennerberg: Repurposing through drug sensitivity screen in AML \n11:10-11:30:    Caroline Heckman: Contextual factors in drug sensitivity screen \n11:30-11:50:    Päivi Östling: Harmonization of Drug sensitivity Screen \nSession 2: Chair: Mika Kontro\, Kim Theilgaard-Mönch\n11:50-12:20:    Martin Jädersten: Real world use of venetoclax \n12:20-12:40:    Kim Theilgaard-Mönch: Interim analysis of the NAMLG trial LD-VenEx \n12:40-13:30:    NAMLG Keynote Lecture \n                           Daniel A Pollyea: Venetoclax in AML: Current state of the art and future development \n13:30-14:30:   LUNCH BREAK\nSession 3: Chairs: Sören Lehmann\, Oscar Brück\n14:30-14:50:    Tom Erkers: Data driven hallmarks in AML \n14:50-15:10:    Thoas Fioretos: Harnessing the Power of Genomics for Improved  Precision Medicine                                                \n15:10-15:40    COFFEE BREAK\nSession 4: Chairs: Bjørn Tore Gjertsen\, Karl-Johan Malmberg \n15:40-16:10:    Mohn Research Centre for Regenerative Medicine (MRCRM) Keynote Lecture \n                           Gunnar Kvalheim: WT1/PRAME RNA-loaded dendritic cell vaccine in AML \n16:10-16:30:   Karl-Johan Malmberg: NK immunotherapy in AML \n16:30-16:50:    Sébastien Walchli: CAR T in AML \n18:10-19:15 RECEPTION IN HAAKONSHALLEN\, BERGEN MUNCIPALITY\n19:45            CONFERENCE DINNER\n______________________________________________________________________ \nDay 2: Friday August 25\, 2023\nSession 5: Chairs: Anne-Sophie von Krogh\, Marianne Tang Severinsen\n08:15-08:45:     Gunnar Juliusson: Challenges of the new AML classifications and guidelines \n08:45 – 09:00:  Discussion \n09:00 – 09:30:  NAMLG Keynote Lecture  \n                             Gerwin Huls: AML therapy backbone and the future of targeted therapies \n09:30 – 09:50: Hans Beier Ommen: Measurable residual disease monitoring \n09:50 – 10:10:  Marianne Tang Severinsen: Registries in AML and a Nordic cohort of AML \n10:10 – 10:40:  Oscar Brück: Data Lake and collection of data for real world epidemiology \n10:40 – 11:10 COFFEE BREAK\nSession 6: Chairs: Caroline Heckman\, JJ Schuringa\n11:10 – 11:40:  NAMLG Keynote Lecture  \n                           J.J. Schuringa: Tumor-stromal interactions in AML \n11:40 – 12:00:  Mika Kontro: Novel macrophage re-programmer bexmarilimab in myeloid malignancies \n12:00 –12:30:  CCBIO Keynote Lecture – Centre for Cancer Biomarker UiB \n                            Jeffrey Tyner: Big data for novel therapeutic strategies in myeloid malignancies \n12:30 – 13:30: LUNCH BREAK\nSession 7: Chairs: James Lorens\, Krister Wennerberg\n13:30 – 13:45: James Lorens: Axl as therapeutic target in cancer \n13:45 – 14:15: CCBIO Keynote Lecture – Centre for Cancer Biomarker UiB \n                          Sonia Loges: AXL in AML \n14:15 – 14:45: CCBIO Keynote Lecture – Centre for Cancer Biomarker UiB  \n                          Uwe Platzbecker: Bemcentinib and Axl in MDS and AML. \nSession 8: Chairs: Jean Christoph Bourdon; Andrea Lenartova\n14:45 – 15:05: Jean Cristoph Bourdon: p53 and its isoforms in cancer \n15:05 – 15:45: CCBIO Keynote Lecture – Centre for Cancer Biomarker UiB \n                          Eva Hellström-Lindberg: TP53 mutations in MDS and AML \n15:45 – 16:15 COFFEE BREAK\nSession 9: Chair: Pia Ettala\, Vladimir Lazarevic \n16:15 – 16:45:  Martin Höglund: The therapeutic landscape in the Nordics: fit and unfit patients in a regional collaboration \n16:45 – 17:00: Closing remarks: Mika Kontro\, Secretary\, NAMLG \nRegistration
URL:https://www.namlg.org/event/nordic-aml-meeting-2023/
LOCATION:Radisson BLU Royal Hotel\, Bergen\, Norway
ATTACH;FMTTYPE=image/jpeg:https://www.namlg.org/wp-content/uploads/2022/09/bryggenibergen.jpg
END:VEVENT
END:VCALENDAR